RootsAnalysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers,2020-2030.”
Screeningsmall molecule fragments has made it possible to identify pharmacological leadsagainst otherwise hard to target hotspots on biomolecules, such as allostericsites, rendering this approach a valuable alternative method of drug discovery
Thereport features an extensive study of the current market landscape, offering aninformed opinion on the likely adoption of this approach over the next decade.It features an in-depth analysis, highlighting the capabilities of variousstakeholders engaged in this domain. In addition to other elements, the studyincludes:
· A detailed review of the overall landscape offragment-based drug discovery library and service providers.
· Elaborate profiles of the companies providinglibraries and services for fragment-based drug discovery (shortlisted on thebasis of the service portfolio and number of fragment screening techniquesoffered).
· An analysis of the partnerships that havebeen established in the recent past.
· A detailed analysis on acquisition targets.
· An insightful competitiveness analysis offragment-based drug discovery library and service providers.
· An analysis highlighting the cost savingpotential associated with the use of fragment-based drug discovery approach.
GetDetailed Analysis: https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
Typeof Technique
· X-ray Crystallography
· Nuclear Magnetic Resonance
· Surface Plasmon Resonance
· Other Screening Techniques
Typeof Service
· Library Screening
· Fragment Screening
· Fragment Optimization
EndUser
· Industry Players
· Non-Industry Players
KeyGeographical Region
· North America (US and Canada)
· Europe (UK, France, Germany, Spain, Italy,and rest of Europe)
· Asia-Pacific (China, Japan, India, and restof Asia-Pacific / rest of the world)
Keycompanies covered in the report
· 2bind
· Charles River Laboratories
· ChemAxon
· ComInnex
· Creative Biolabs
· Creative Biostructure
· CRELUX
· Domainex
· Evotec
· Red Glead Discovery
· SARomics Biostructures
· Shanghai ChemPartner
· Sygnature Discovery
· Vernalis Research
Requestfor Customization:
https://www.rootsanalysis.com/reports/309/request-customization.html
ChapterOutlines
Chapter2 isan executive summary of the insights captured in our research. It offers ahigh-level view on the current state of the market for fragment-based drug discoveryand its likely evolution in the short-mid-term and long term.
Chapter3 providesan introduction to the process of drug discovery and development. In addition,the chapter focuses on the concept of fragment-based drug discovery,highlighting its key advantages and drawbacks. It also features a briefdiscussion on the opportunities and the likely future trends in this field.
Chapter4 providesa detailed overview of the current market landscape of fragment-based drugdiscovery, including information on library and service providers, type ofproduct (library and technology), type of service offered (fragment screeningand fragment optimization), type of technique used (X-ray crystallography,nuclear magnetic resonance, surface plasmon resonance, and other screeningtechniques), other services offered (target identification / validation, hitidentification, hit-to-lead / lead generation and lead optimization) and enduser (industry players and non-industry players).
Chapter5 includesdetailed profiles of the companies providing library and services forfragment-based drug discovery (shortlisted on the basis of the serviceportfolio and number of fragment screening techniques offered). Each profilefeatures a brief overview of the company, its financial information (ifavailable), fragment-based library and service portfolio, information on otherdrug discovery services, recent developments and an informed future outlook.
Chapter6 featuresan elaborate analysis of the partnerships that have been inked among variousstakeholders in this domain, during 2015-2020. It includes a brief descriptionof partnership models (such as research and development agreements, mergers andacquisitions, product development and commercialization agreements,distribution and supply agreements, service alliances, and commercializationagreements) adopted by the stakeholders.
Chapter7 providesa detailed acquisition target analysis, taking into consideration thehistorical trend of the activity of the companies that have acquired otherfirms since 2015, and offering a means for other industry stakeholders toidentify potential acquisition targets.
Chapter8 providesan insightful competitiveness analysis of fragment-based drug discovery libraryand service providers, featuring a two-dimensional scatter plot representation.It highlights the key players in this domain, taking into consideration the supplierpower (based on the year of establishment of service provider) and keyspecifications, such as number of fragment libraries and number of screeningtechniques.
Chapter9 providesan analysis highlighting the cost saving potential associated with the use offragment-based drug discovery approach.
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
Alsohave a Look on Our Upcoming Research Reports
Soft Tissue Sarcoma: Pipeline Review,Developer Landscape and Competitive Insights, 2021-2031
Spinal Muscular Atrophy Market, 2021-2031
